ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,656Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 1107

$1.34M Total Retail Price of All Prescriptions

Rank: 43 out of 1107

733 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 733 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 16,857 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 953 550 S3 1 1
LEVOTHYROXINE SODIUM 862 598 2 3
OMEPRAZOLE 780 496 3 4
AMLODIPINE BESYLATE 654 494 4 6
FUROSEMIDE 641 546 5 7
SIMVASTATIN 589 459 6 5
LISINOPRIL 587 419 7 2
METFORMIN HCL 538 342 8 8
METOPROLOL TARTRATE 469 407 9 10
POTASSIUM CHLORIDE 386 344 10 14
CITALOPRAM HBR 375 281 11 17
ATORVASTATIN CALCIUM 364 270 12 13
PRAVASTATIN SODIUM 337 235 13 12
GABAPENTIN 327 172 14 9
METOPROLOL SUCCINATE 256 207 15 16
MELOXICAM 242 143 16 25
ZOLPIDEM TARTRATE 241 167 17 22
BISOPROLOL-HYDROCHLOROTHIAZIDE 236 203 18 164
GEMFIBROZIL 226 186 19 107
RANITIDINE HCL 224 155 20 21
LOSARTAN POTASSIUM 218 151 21 29
METHOCARBAMOL 207 76 R 22 142
HYDROCHLOROTHIAZIDE 200 164 23 11
CRESTOR 196 137 24 23
NAMENDA 193 189 25 42
ALPRAZOLAM 190 163 26 87
CYMBALTA 189 88 27 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 179 91 28 24
NEXIUM 177 76 29 18
ZETIA 174 132 30 76
WARFARIN SODIUM 173 156 31 15
CLOPIDOGREL 171 126 32 28
ATENOLOL 167 108 33 19
SERTRALINE HCL 162 88 34 20
DONEPEZIL HCL 161 157 35 32
ISOSORBIDE MONONITRATE ER 155 143 36 34
JANUVIA 154 107 37 60
CARVEDILOL 148 138 38 27
TRIAMTERENE-HCTZ 143 132 39 62
SULFAMETHOXAZOLE-TRIMETHOPRIM 141 98 40 88
FLUOXETINE HCL 141 62 40 47
TAMSULOSIN HCL 140 132 42 30
FENOFIBRATE 136 85 43 67
CARISOPRODOL 136 40 R 43 146
PLAVIX 135 104 45 39
AZITHROMYCIN 135 95 45 35
CIPROFLOXACIN HCL 134 106 47 59
GLIMEPIRIDE 130 65 48 43
PREDNISONE 125 96 49 40
OXYCODONE-ACETAMINOPHEN 124 71 S2 50 104
ALENDRONATE SODIUM 123 105 51 41
TRAMADOL HCL 115 61 52 26
SYNTHROID 114 107 53 70
TRICOR 110 91 54 95
FLUTICASONE PROPIONATE 108 64 55 38
LIPITOR 106 71 56 109
TRAZODONE HCL 104 65 57 33
DILTIAZEM 24HR ER 103 71 58 172
AMOXICILLIN 103 63 58 90
THEOPHYLLINE ANHYDROUS 103 74 58 158
SPIRIVA 99 62 61 57
PROMETHAZINE HCL 98 56 R 62 44
POLYETHYLENE GLYCOL 3350 98 79 62 46
ALLOPURINOL 97 91 64 36
AMITRIPTYLINE HCL 96 50 R 65 48
DIOVAN 95 79 66 51
BUMETANIDE 92 81 67 123
VERAPAMIL ER 90 51 68 113
ONGLYZA 89 77 69 205
LANSOPRAZOLE 88 52 70 102
TRIAMCINOLONE ACETONIDE 88 72 70 137
VENLAFAXINE HCL ER 87 59 72 117
QUETIAPINE FUMARATE 87 60 72 94
AMLODIPINE BESYLATE-BENAZEPRIL 85 84 74 77
SOTALOL 84 76 75 222
CLONIDINE HCL 83 61 76 53
LYRICA 83 15 76 83
SINGULAIR 82 60 78 65
FAMOTIDINE 81 74 79 111
CARBIDOPA-LEVODOPA 81 74 79 122
DOXAZOSIN MESYLATE 81 77 79 92
DIGOXIN 80 76 82 52
LOSARTAN-HYDROCHLOROTHIAZIDE 79 50 83 66
BENAZEPRIL HCL 79 44 83 86
DIOVAN HCT 78 64 85 106
PROAIR HFA 78 44 85 37
ESCITALOPRAM OXALATE 77 56 87 82
BYSTOLIC 72 54 88 138
CYCLOBENZAPRINE HCL 70 16 R 89 56
KLOR-CON M20 68 67 90 75
ADVAIR DISKUS 68 29 90 54
LEVOFLOXACIN 68 53 90 71
HYDROXYZINE HCL 67 52 R 93 162
MORPHINE SULFATE ER 67 32 S2 93 156
CLONAZEPAM 64 48 95 220
GLIPIZIDE XL 64 50 95 166
TOPIRAMATE 62 11 97 160
FENTANYL 61 36 S2 98 105
NIASPAN 56 47 99 125
DETROL LA 56 48 99 223
VYTORIN 56 31 99 169
METOCLOPRAMIDE HCL 55 33 102 116
DOXYCYCLINE HYCLATE 54 28 103 128
NOVOLOG 53 22 104 127
EXELON 53 53 104 103
DILTIAZEM ER 53 41 104 139
NIFEDIPINE ER 53 50 104 168
LORAZEPAM 52 46 108 155
INDOMETHACIN 52 22 R 108 313
INSULIN SYRINGE 52 35 108 78
TIZANIDINE HCL 52 24 108 73
PHENYTOIN SODIUM EXTENDED 52 15 108 147
BUSPIRONE HCL 51 24 113 107
FLUCONAZOLE 50 31 114 150
COMBIVENT 50 36 114 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.